1/13
03:17 pm
inbx
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too [Seeking Alpha]
Low
Report
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too [Seeking Alpha]
12/28
10:27 am
inbx
Inhibrx Advances Key Oncology Programs Toward Multiple 2026 Data Readouts [Yahoo! Finance]
Low
Report
Inhibrx Advances Key Oncology Programs Toward Multiple 2026 Data Readouts [Yahoo! Finance]
12/16
05:36 pm
inbx
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program [Yahoo! Finance]
Low
Report
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program [Yahoo! Finance]
12/16
05:00 pm
inbx
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
Low
Report
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
11/21
11:04 am
inbx
Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap [Seeking Alpha]
Medium
Report
Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap [Seeking Alpha]
11/19
07:01 am
inbx
Inhibrx Biosciences (NASDAQ:INBX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Inhibrx Biosciences (NASDAQ:INBX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
11/14
06:37 am
inbx
Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]
Medium
Report
Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]
11/14
06:07 am
inbx
Inhibrx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Inhibrx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/14
06:00 am
inbx
Inhibrx Reports Third Quarter 2025 Financial Results
Medium
Report
Inhibrx Reports Third Quarter 2025 Financial Results
11/4
04:13 pm
inbx
Inhibrx Announces Participation in Upcoming Scientific Conferences [Yahoo! Finance]
Low
Report
Inhibrx Announces Participation in Upcoming Scientific Conferences [Yahoo! Finance]
11/4
04:01 pm
inbx
Inhibrx Announces Participation in Upcoming Scientific Conferences
Low
Report
Inhibrx Announces Participation in Upcoming Scientific Conferences
10/23
06:46 pm
inbx
Inhibrx shares surge after bone cancer drug slows disease progression in trial [Yahoo! Finance Canada]
High
Report
Inhibrx shares surge after bone cancer drug slows disease progression in trial [Yahoo! Finance Canada]
10/23
04:05 pm
inbx
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
High
Report
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
10/22
04:31 pm
inbx
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts [Yahoo! Finance]
High
Report
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts [Yahoo! Finance]
10/22
04:01 pm
inbx
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
High
Report
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts